Proteomic screening of glycoproteins in human plasma for frailty biomarkers

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 67 A, Issue 8, 2012, Pages 853-864

  Shamsi, Kinza S ^a   Pierce, Anson ^b   Ashton, Aaron S ^a   Halade, Dipti G ^c,d   Richardson, Arlan ^a,c,d   Espinoza, Sara E ^a,c,d  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Frailty; Proteomics

Indexed keywords

BIOLOGICAL MARKER; FIBRINOGEN; GLYCOPROTEIN; HAPTOGLOBIN; LECTIN; TRANSFERRIN;

AFFINITY CHROMATOGRAPHY; AGED; ARTICLE; BLOOD; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FRAIL ELDERLY; HUMAN; MASS SPECTROMETRY; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHROMATOGRAPHY, AFFINITY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRINOGEN; FRAIL ELDERLY; GLYCOPROTEINS; HAPTOGLOBINS; HUMANS; LECTINS; MASS SPECTROMETRY; PROTEOMICS; TRANSFERRIN;

EID: 84866387008     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glr224     Document Type: Article

References (37)

1. Fried LP, Walston J. Frailty and failure to thrive. In: Hazzard WR, Blass JP, Ettinger WH Jr, Halter JB, Ouslander J, eds. Principles of Geriatric Medicine and Gerontology, 4th ed. New York, NY: McGraw Hill Publisher; 1998: 1387 - 1402.
2. Walston J, McBurnie MA, Newman A, et al. Frailty and activation of the infl ammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med. 2002; 162 (20): 2333 - 2341.
3. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56 (3): M146 - M156.
4. Walston J, Hadley EC, Ferrucci L, et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc. 2006; 54 (6): 991 - 1001.
5. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002; 1 (11): 845 - 867.
6. [erratum appears in Mol Cell Proteomics. 2003 Jan;2(1):50].
7. Jung K, Cho W, Regnier FE. Glycoproteomics of plasma based on narrow selectivity lectin affi nity chromatography. J Proteome Res. 2009; 8 (2): 643 - 650.
8. Axford J, Kieda C, van Dijk W. Meeting report: glycobiology and medicine. Glycobiology. 2001; 11 (2): 5G - 7G.
9. Apweiler R, Hermjakob H, Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta. 1999; 1473 (1): 4 - 8.
10. Fedarko NS. The biology of aging and frailty. Clin Geriatr Med. 2011; 27: 27 - 37.
11. Yoshida H. ER stress and diseases. FEBS J. 2007; 274 (3): 630.
12. Espinoza SE, Hazuda HP. Frailty in older Mexican American and European American adults: is there an ethnic disparity? J Am Geriatr Soc. 2008; 56 (9): 1744 - 1749.
13. Qiu R, Regnier FE. Use of multidimensional lectin affi nity chromatography in differential glycoproteomics. Anal Chem. 2005; 77 (9): 2802 - 2809.
14. Kanapuru B, Ershler WB. Infl ammation, coagulation, and the pathway to frailty. Am J Med. 2009; 122 (7): 605 - 613.
15. Quaye IK. Haptoglobin, infl ammation and disease. Trans R Soc Trop Med Hyg. 2008; 102 (8): 735 - 742.
16. Howard C, Ferrucci L, Sun K, et al. Oxidative protein damage is associated with poor grip strength among older women living in the community. J Appl Physiol. 2007; 103 (1): 17 - 20.
17. Ding J, Kopchick JJ. Plasma biomarkers of mouse aging. Age(Dordr). 2010; 33 (3): 291 - 307.
18. Byerley LO, Leamy L, Tam SW, et al. Development of a serum profi le for healthy aging. Age(Dordr). 2010; 32: 497 - 507.
19. Delanghe JR, Langlois MR. Hemopexin: a review of biological aspects and the role in laboratory medicine. Clin Chim Acta. 2001; 312: 13 - 23.
20. Yang FM, Friedrichs WE, Buchanan JM, et al. Tissue specifi c expression of mouse transferrin during development and aging. Mech Ageing Dev. 1990; 56 (2): 187 - 197.
21. Müller-Esterl W, Johnson DA, Salvesen G, et al. Human kininogens. In: G Di Sabato, ed. Methods in Enzymology. Linn, MO: Academic Press; 1988: 240 - 256.
22. Arnold JN, Wormald MR, Sim RB, et al. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol. 2007; 25: 21 - 50.
23. Bradford HN, Dela Cadena RA, Kunapuli SP, et al. Human kininogens regulate thrombin binding to platelets through the glycoprotein Ib-IX-V complex. Blood. 1997; 90 (4): 1508 - 1515.
24. Reiner AP, Aragaki AK, Gray SL, et al. Infl ammation and thrombosis biomarkers and incident frailty in postmenopausal women. Am J Med. 2009; 122: 947 - 954.
25. Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer ' s disease. Neuron. 2009; 63: 287 - 303.
26. Buchman AS, Boyle PA, Wilson RS, et al. Frailty is associated with incident Alzheimer ' s disease and cognitive decline in the elderly. Psychosom Med. 2007; 69: 483 - 489.
27. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12 (3): 189 - 198.
28. Weivoda S, Andersen JD, Skogen A, et al. ELISA for human serum leucine-rich-2-glycoprotein-1 employing cytochrome c as the capturing ligand. J Immunol Methods. 2008; 336: 22 - 29.
29. Cohen HJ, Harris T, Pieper CF. Coagulation and activation of infl ammatory pathways in the development of functional decline and mortality in the elderly. Am J Med. 2003; 114: 180 - 187.
30. Wilcox BJ, Donlon TA, He Q, et al. FOXO3A genotype is strongly associated with human longevity. Proc Natl Acad Sci U S A. 2008; 105 (37): 13987 - 13992.
31. Lu YAJ, Wang G, Hao H, et al. Gas chromatography/time-of-fl ight mass spectrometry based metabonomic approach to differentiating hypertension- and age-related metabolic variation in spontaneously hypertensive rats. Rapid Commun Mass Spectrom. 2008; 22: 2882 - 2888.
32. Yang Z, Hancock WS. Approach to the comprehensive analysis of glycoproteins isolated from human serum using a multi-lectin affi nity column. J Chromatogr A. 2004; 1053 (1 - 2): 79 - 88.
33. Drake RR, Schwegler EE, Malik G, et al. Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. Mol Cell Proteomics. 2006; 5 (10): 1957 - 1967.
34. Yang Z, Hancock WS, Chew TR, et al. A study of glycoproteins in human serum and plasma reference standards (HUPO) using multilectin affi nity chromatography coupled with RPLC-MS/MS. Proteomics. 2005; 5 (13): 3353 - 3366.
35. Surinova S, Schiess R, Huttenhain R, et al. On the development of plasma protein biomarkers. J Proteome Res. 2011; 10 (1): 5.
36. Schiess R, Wollscheid B, Aebersold R. Targeted proteomic strategy for clinical biomarker discovery. Mol Oncol. 2009; 3 (1): 33.
37. Fried LP, Xue Q, Cappola AR, et al. Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. J Gerontol A Biol Sci Med Sci. 2009; 64 (10): 1049 - 1057.